Evidence map›Paper›PMID 24955608›Full record

ArticleThe Journal of clinical endocrinology and metabolism2014

Adipose tissue 12/15 lipoxygenase pathway in human obesity and diabetes.

David C Lieb, Joshua J Brotman, Margaret A Hatcher, Myo S Aye, Banumathi K Cole, Bronson A Haynes, Stephen D Wohlgemuth, Mark A Fontana, Hind Beydoun, Jerry L Nadler and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

David C LiebDepartments of Internal Medicine (D.C.L., B.K.C., J.L.N.) and Physiological Sciences (J.J.B., M.A.H., M.S.A., B.A.H., A.D.D.) and Graduate Program in Public Health (H.B.), Eastern Virginia Medical School, Norfolk, Virginia 23507; and Sentara Metabolic and Weight Loss Surgery Center (S.D.W., M.A.F.), Sentara Medical Group, Norfolk, Virginia 23502.
Joshua J Brotman
Margaret A Hatcher
Myo S Aye
Banumathi K Cole
Bronson A Haynes
Stephen D Wohlgemuth
Mark A Fontana
Hind Beydoun
Jerry L Nadler
Anca D Dobrian
Eastern Virginia Medical School · USSentara Norfolk General Hospital · US

Funding

Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and AtherosclerosisR01HL112605 · NHLBI · EASTERN VIRGINIA MEDICAL SCHOOL · PI NADLER, JERRY L. · 2012 to 2016
$2.0M
12/15 Lipoxygenases Role in Inflammation and Angiogenesis in Human Adipose TissueR15HL114062 · NHLBI · EASTERN VIRGINIA MEDICAL SCHOOL · PI DOBRIAN, ANCA D · 2013 to 2013
$366k
NHLBI NIH HHS R01 HL112605NHLBI NIH HHS R01HL112605NHLBI NIH HHS R15 HL114062NHLBI NIH HHS R15HL114062
6 · The paper itself

Abstract

contextVisceral adipose tissue (VAT) is a key contributor to chronic inflammation in obesity. The 12/15-lipoxygenase pathway (ALOX) is present in adipose tissue (AT) and leads to inflammatory cascades that are causal for the onset of insulin resistance in rodent models of obesity.

objectiveThe pathophysiology of the ALOX 12/15 pathway in human AT is unknown. We characterized the ALOX pathway in different AT depots in obese humans with or without type 2 diabetes (T2D).

designThis study includes a cross-sectional cohort of 46 morbidly obese (body mass index >39 kg/m(2)) nondiabetic (n = 25) and T2D (n = 21) subjects.

settingThis study was conducted at Eastern Virginia Medical School (Norfolk, Virginia) in collaboration with Sentara Metabolic and Weight Loss Surgery Center (Sentara Medical Group, Norfolk, Virginia). PATIENTS: Twenty-five obese (body mass index 44.8 ± 4.4 kg/m(2)) nondiabetic (hemoglobin A1c 5.83% ± 0.27%) and 21 obese (43.4 ± 4.1 kg/m(2)) and T2D (hemoglobin A1c 7.66% ± 1.22%) subjects were included in the study. The subjects were age matched and both groups had a bias toward female gender. MAIN OUTCOMES AND MEASURES: Expression of ALOX isoforms along with fatty acid substrates and downstream lipid metabolites were measured. Correlations with depot-specific inflammatory markers were also established.

resultsALOX 12 expression and its metabolite 12(S)-hydroxyeicosatetraenoic acid were significantly increased in the VAT of T2D subjects. ALOX 15A was exclusively expressed in VAT in both groups. ALOX 12 expression positively correlated with expression of inflammatory genes IL-6, IL-12a, CXCL10, and lipocalin-2.

conclusionsALOX 12 may have a critical role in regulation of inflammation in VAT in obesity and T2D. Selective ALOX 12 inhibitors may constitute a new approach to limit AT inflammation in human obesity.

Indexed as

AdolescentAdultAgedArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseBiomarkersCross-Sectional StudiesDiabetes Mellitus, Type 2Fatty AcidsFemaleGene Expression Regulation, EnzymologicGlycated HemoglobinHumansInflammationIntra-Abdominal FatLipid MetabolismALOX12 protein, humanALOX15 protein, humanArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseBiomarkersFatty AcidsGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID24955608
PMCPMC4154098
OpenAlexW2034829797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.